PT - JOURNAL ARTICLE AU - Juan Pablo Diaz Martinez AU - Karen Janik Orozco Becerril AU - Marco Antonio Gallegos Herrada AU - Mayra Alejandra Gutierrez Garcia AU - Osvaldo Espin-Garcia AU - Ruth Fuentes Garcia TI - Multi-level multi-state modelling applied to hospital admission in mexican patients with COVID-19 AID - 10.1101/2021.05.24.21257752 DP - 2021 Jan 01 TA - medRxiv PG - 2021.05.24.21257752 4099 - http://medrxiv.org/content/early/2021/05/26/2021.05.24.21257752.short 4100 - http://medrxiv.org/content/early/2021/05/26/2021.05.24.21257752.full AB - Since the beginning of the SARS-CoV 2 pandemic, healthcare authorities have made clear that it is crucial to track and identify COVID-19 symptoms and seek medical attention in the presence of the first warning signs, as immediate medical attention can improve the patient’s prognosis. Therefore the present work aims to analyze the risks associated with the time between the patient’s first symptoms and hospitalization followed by death. A cross-sectional study was performed among Mexican population diagnosed with COVID-19 and hospitalized from March to January 2021. Four different Bayesian models were developed to asses the risk associated with different patient trajectories: symptoms-hospitalization and hospitalization-death. Comorbidities that could worsen the patient outcome were included as linear predictions; these analyses were further broken down to the different states of the Mexican Republic and the healthcare providers within. Model III was chosen as the best performance through a validation of leaving one out (LOO). Increased risk for hospitalization was observed at the global population level for chronic renal disease, whereas for death such was the case for COPD and the interaction of diabetes:hypertension:obesity. Our results show that there are differences in mortality between the states without accounting for institution and it is related to the prompt time of death or viceversa. Regarding the 6 healthcare providers included in the analysis differences were also found. While state-managed hospitals and private sector showed lower risks, in contrast the IMSS seems to be the one with the highest risk. The proposed modelling can be helpful to improve healthcare assistance at a regional level, additionally it could inform statistical parameter inference in epidemiological models.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe project was funded by the mexican science council, CONACYT, project 312045.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Information for this observational study is publicly available and was provided the Mexican Ministry of Health.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesInformation is taken from the Mexican Ministry of Health (SISVER). https://datos.gob.mx/busca/dataset/informacion-referente-a-casos-covid-19-en-mexico